Albert David Stock Screener | Share Price & Fundamental Analysis
ALBERTDAVD
Pharmaceuticals
Screen Albert David share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹763.90
▲
18.15 (2.43%)
Share Price BSE
₹758.25
▲
7.55 (1.01%)
Market Cap
₹435.97 Cr.
P/E Ratio (TTM)
-28.42
P/B Ratio
1.09
EPS (TTM)
₹30.14
Dividend Yield
0.67%
Debt to Equity
0.02
52W High
₹1301.35
52W Low
₹736.60
Operating Margin
-4.00%
Profit Margin
-4.66%
Revenue (TTM)
₹322.00
EBITDA
₹-6.00
Net Income
₹-15.00
Total Assets
₹511.00
Total Equity
₹393.00
Albert David Share Price History - Stock Screener Chart
Screen ALBERTDAVD historical share price movements with interactive charts. Analyze price trends and patterns.
Albert David Company Profile - Fundamental Screener
Screen Albert David company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ALBERTDAVD shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE155C01010
Albert David Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ALBERTDAVD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 511 | 498 | 423 | 401 | 341 | 320 | 295 | 290 | 285 | 224 |
| Current Assets | 354 | 372 | 304 | 253 | 223 | 201 | 186 | 172 | 164 | 152 |
| Fixed Assets | 99 | 83 | 80 | 88 | 84 | 91 | 77 | 83 | 87 | 44 |
| Liabilities | ||||||||||
| Total Liabilities | 511 | 498 | 423 | 401 | 341 | 320 | 295 | 290 | 285 | 224 |
| Current Liabilities | 15 | 16 | 13 | 14 | 16 | 16 | 16 | 15 | 14 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 393 | 383 | 312 | 280 | 244 | 223 | 210 | 186 | 183 | 137 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 387 | 377 | 306 | 274 | 239 | 217 | 205 | 180 | 177 | 131 |
Screen ALBERTDAVD income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 322 | 375 | 420 | 357 | 329 | 265 | 328 | 324 | 296 | 303 | 325 | 324 |
| Expenses | 328 | 343 | 316 | 297 | 273 | 228 | 291 | 287 | 266 | 268 | 292 | 285 |
| EBITDA | -6 | 33 | 104 | 60 | 57 | 36 | 37 | 36 | 31 | 36 | 33 | 38 |
| Operating Profit % | -4.00% | 1.00% | 13.00% | 13.00% | 13.00% | 8.00% | 9.00% | 9.00% | 8.00% | 9.00% | 10.00% | 11.00% |
| Depreciation | 8 | 7 | 7 | 9 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 15 |
| Interest | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| Profit Before Tax | -16 | 25 | 97 | 51 | 47 | 27 | 29 | 29 | 22 | 27 | 63 | 20 |
| Tax | 3 | 8 | 22 | 15 | 12 | 5 | 10 | 11 | 8 | 10 | 15 | 7 |
| Net Profit | -15 | 17 | 75 | 36 | 35 | 22 | 19 | 18 | 14 | 17 | 48 | 14 |
| EPS | -26.40 | 30.14 | 132.15 | 63.39 | 61.78 | 38.80 | 33.59 | 46.68 | 17.24 | 27.96 | 84.10 | 24.01 |
Albert David Cash Flow Screener - Liquidity Fundamentals
Screen ALBERTDAVD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -28 | 46 | 11 | 40 | 37 | 30 | 32 | 30 | 20 | 68 |
| Investing Activities | 23 | -33 | -5 | -40 | -37 | -20 | -19 | -11 | -36 | -38 |
| Financing Activities | 0 | -8 | -6 | -2 | -2 | -10 | -17 | -5 | 7 | -18 |
| Net Cash Flow | -5 | 4 | -1 | -1 | -2 | 0 | -4 | 15 | -10 | 12 |
Screen ALBERTDAVD shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.24% | 62.24% | 62.24% | 62.13% | 62.13% | 62.13% | 62.13% | 62.04% |
| FII Holding | 1.01% | 0.84% | 0.60% | 0.98% | 0.80% | 0.88% | 0.86% | 0.00% |
| DII Holding | 1.65% | 1.66% | 1.66% | 1.67% | 1.67% | 1.64% | 1.64% | 2.80% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.43% | 27.81% | 27.72% | 26.71% | 27.27% | 27.63% | 27.92% | 27.36% |
| Other Holding | 7.68% | 7.45% | 7.78% | 8.51% | 8.13% | 7.72% | 7.45% | 7.79% |
| Shareholder Count | 15,304 | 15,070 | 14,666 | 11,266 | 12,349 | 13,590 | 14,830 | 10,010 |
Albert David Dividend Screener - Share Yield Analysis
Screen ALBERTDAVD dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹5.00 | 0.67% |
| 2024-March | ₹11.50 | 1.42% |
| 2023-March | ₹9.00 | 0.84% |
| 2022-March | ₹9.00 | 1.73% |
| 2021-March | ₹6.00 | 1.13% |
| 2020-March | ₹7.00 | 1.86% |
| 2019-March | ₹6.00 | 1.88% |
| 2018-March | ₹5.50 | 1.41% |
| 2017-March | ₹5.50 | 1.50% |
Albert David Index Membership - Market Screener Classification
Screen ALBERTDAVD by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Albert David Market Events Screener - Corporate Actions
Screen ALBERTDAVD market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 6.00 /share | 18.32% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 2.06% |
| 2025-08-02 | 2025-08-02 | Annual General Meeting | NA | -2.95% |
| 2025-08-02 | 2025-08-02 | Quarterly Result Announcement | NA | -3.81% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 5.00 /share | 0.89% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 7.09% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.77% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.51% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 12.46% |
| 2024-08-02 | 2024-08-02 | Dividend | ₹ 11.50 /share | 15.99% |
| 2023-08-03 | 2023-08-03 | Dividend | ₹ 9.00 /share | 27.61% |
| 2022-08-01 | 2022-08-02 | Dividend | ₹ 9.00 /share | 1.18% |
Albert David Competitors Screener - Peer Comparison
Screen ALBERTDAVD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,705 | 40.28 | 54,729 | 9.71% | 10,980 | 58.99 |
| Divis Laboratories | 176,338 | 70.98 | 9,712 | 18.67% | 2,191 | 63.15 |
| Torrent Pharmaceuticals | 138,499 | 62.26 | 11,539 | 6.99% | 1,911 | 80.95 |
| Cipla | 118,573 | 22.75 | 28,410 | 7.12% | 5,291 | 38.52 |
| Dr Reddys Laboratories | 103,728 | 18.27 | 33,741 | 16.73% | 5,725 | 40.17 |
| Lupin | 101,149 | 22.61 | 22,910 | 13.74% | 3,306 | 71.67 |
| Mankind Pharma | 95,432 | 52.17 | 12,744 | 20.90% | 2,007 | 64.16 |
| Zydus Life Science | 93,333 | 18.63 | 23,511 | 18.55% | 4,615 | 52.14 |
| Aurobindo Pharma | 71,752 | 20.91 | 32,346 | 9.43% | 3,484 | 61.25 |
| Alkem Laboratories | 69,425 | 28.04 | 13,458 | 3.70% | 2,216 | 63.97 |
Albert David Company Announcements - News Screener
Screen ALBERTDAVD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-22 | Closure of Trading Window | View |
| 2025-12-22 | Closure of Trading Window | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Resignation of Managing Director | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO) | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-18 | Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Resignation Of Managing Director CEO & Director | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Dated 12.11.2025 | View |
| 2025-11-05 | Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-01 | Intimation Of Board Meeting To Approve Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-10-08 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-10-08 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-20 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-17 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |